Insights

Global Market Presence Linical's established footprint across Japan, North America, Europe, and Asia-Pacific positions it well to acquire multinational clients seeking comprehensive CRO services and seamless international trial management.

Specialized Service Offerings Focusing on high-growth therapeutic areas like oncology, neurology, immunology, and metabolic diseases, Linical can target pharmaceutical companies advancing drugs in these sectors, enhancing partnership opportunities.

Tech-Enabled Operations Utilization of advanced platforms such as Salesforce, Veeva Vault, and Microsoft 365 indicates a modern, efficient approach, making Linical attractive to clients valuing technological integration and data security.

Mid-Scale Revenue With revenue between 100 million and 250 million dollars and a dedicated team of up to 1,000 staff, Linical presents opportunities for mid-tier collaborations to expand project capacities and global reach.

Growth and Funding Opportunities Although recent funding data is not specified, Linical's continued focus on full-service drug development and active market presence suggest potential for strategic investments or partnerships to accelerate growth and service expansion.

Linical Tech Stack

Linical uses 8 technology products and services including D2L Brightspace, HubSpot Cookie Policy Banner, Salesforce, and more. Explore Linical's tech stack below.

  • D2L Brightspace
    Communication And Collaboration
  • HubSpot Cookie Policy Banner
    Cookie Compliance
  • Salesforce
    Customer Relationship Management
  • Microsoft 365
    Email
  • Veeva Vault
    Enterprise Content Management
  • Preact
    Javascript Libraries
  • Apache
    Web Servers
  • Twitter
    Widgets

Linical's Email Address Formats

Linical uses at least 1 format(s):
Linical Email FormatsExamplePercentage
First.Last@linical.comJohn.Doe@linical.com
47%
FLast@linical.comJDoe@linical.com
5%
Last.First@linical.comDoe.John@linical.com
1%
First.Last@linical.comJohn.Doe@linical.com
47%

Frequently Asked Questions

What is Linical's stock symbol?

Minus sign iconPlus sign icon
Linical is a publicly traded company; the company's stock symbol is WCGC.

What is Linical's official website and social media links?

Minus sign iconPlus sign icon
Linical's official website is linical.com and has social profiles on LinkedIn.

What is Linical's SIC code NAICS code?

Minus sign iconPlus sign icon
Linical's SIC code is 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Linical have currently?

Minus sign iconPlus sign icon
As of December 2025, Linical has approximately 501 employees across 4 continents, including EuropeNorth AmericaAsia. Key team members include Chief Information Security Officer (ciso): M. U.Chief Medical Officer: T. G.Chief Scientific Officer: C. M. H.. Explore Linical's employee directory with LeadIQ.

What industry does Linical belong to?

Minus sign iconPlus sign icon
Linical operates in the Pharmaceutical Manufacturing industry.

What technology does Linical use?

Minus sign iconPlus sign icon
Linical's tech stack includes D2L BrightspaceHubSpot Cookie Policy BannerSalesforceMicrosoft 365Veeva VaultPreactApacheTwitter.

What is Linical's email format?

Minus sign iconPlus sign icon
Linical's email format typically follows the pattern of First.Last@linical.com. Find more Linical email formats with LeadIQ.

When was Linical founded?

Minus sign iconPlus sign icon
Linical was founded in 2005.

Linical

Pharmaceutical ManufacturingŌsaka, Japan501-1000 Employees

Linical is a global Contract Research Organization (CRO) for full-service drug development, with a proven record of helping biopharmaceutical companies successfully navigate the clinical development journey. Linical is headquartered in Japan with a significant presence across all major markets including North America, Europe, and Asia-Pacific. 
Linical provides a full spectrum of drug development services from early stage to large-scale, multinational studies. Our areas of focus include Phase I-IV studies in oncology, neurology & psychiatry, immunology & vaccine, and endocrinology & metabolic diseases. 

Combining strong business perspective with clinical and medical expertise, our team goes beyond operational excellence providing flexibility, guidance, and key strategies to successfully overcome drug development and regulatory challenges. We strive to offer professional, high-quality services with the personal attention needed in a constantly evolving pharmaceutical and biotech market. Rather than be all things to the market, this intentional design allows us to provide our clients the right size, right reach, and right team.

Section iconCompany Overview

SIC Code
5122 - Drugs, Drug Proprietaries, and Druggists' Sundries
Stock Symbol
WCGC
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2005
Employees
501-1000

Section iconFunding & Financials

  • $100M$250M

    Linical's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $100M$250M

    Linical's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.